ALERT
Grants will not be considered in Educational Areas for which funding is not currently available.
Grants must be submitted at least 45 days prior to the program start date.

Educational Areas

AstraZeneca is committed to supporting quality independent education that:
  • Meet an educational need by providing information designed to assist health care professionals in their efforts to enhance patient care
  • Further the understanding of emerging therapies based on a documented unmet need
  • Incorporate evidence-based medicine in the program objectives and methodology
  • Assist health care professionals in carrying out diagnosis and treatment strategies more effectively and efficiently
  • Support the efforts of health care professionals to broaden patient knowledge and awareness of disease states and treatment options
  • Address performance and quality improvement

We focus our support where there is the greatest need in areas that overlap with our areas of interest.

We have incorporated Call for Grant Applications into our process. Please check Call for Grant link on the homepage for grant submission details.

CARDIOVASCULAR
Currently Accepting Applications in Response to Call for Grants
Atherosclerosis - CGA closed
Dyslipidemia - CGA closed
Acute Coronary Syndrome

RESPIRATORY
Currently Accepting Applications in Response to Call for Grants
COPD
Asthma

ONCOLOGY
Metastatic Breast Cancer

ENDOCRINOLOGY

Adult Type 2 Diabetes Mellitus
Collaboration between AstraZeneca and Bristol-Myers Squibb

RESEARCH & DEVELOPMENT

Scientific or educational activities designed to educate research scientists, principal researchers, drug development professionals, academics, pre-doctoral students, doctoral students and fellows. These programs must be educational and non-promotional in nature and planned, designed and implemented in accordance with the U.S. Food and Drug Administration's Guidance on Industry-Supported Scientific and Educational Activities.